Literature DB >> 20004145

Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases.

Sophie Larrieu1, Nicolas Pouderoux, Thierry Pistone, Laurent Filleul, Marie-Catherine Receveur, Daouda Sissoko, Khaled Ezzedine, Denis Malvy.   

Abstract

BACKGROUND: In 2005-2006, a major epidemic of CHIKV infection occurred in the Islands of the south-western Indian Ocean, and longstanding manifestations seemed to be more frequent than described before.
OBJECTIVES: To describe the frequency and related factors of late clinical manifestations of CHIKV infection among imported cases living in Aquitaine area, France. STUDY
DESIGN: All patients recruited through the travel clinic and tropical medicine unit of the University Hospital Centre of Bordeaux with possible CHIKV infection were prospectively recorded, and confirmed cases of CHIKV infection were interviewed 2 years after infection. Factors associated with the persistence of symptoms were determined by multivariate logistic regression.
RESULTS: Among the 29 cases followed, 17 still suffered from arthralgia 2 years after infection, and most of them had never recovered from the initial phase of the condition. The risk of persistent arthralgia tended to be higher among subjects with low educational level, subjects infected in the Reunion Island, and when initial phase lasted 30 days or more and was characterised by a severe pain.
CONCLUSIONS: Consistent with previous studies, our findings showed worsened late manifestations among patients returning from Indian Ocean area. Persistence of symptoms tended to be linked with clinical burden during the acute phase, which can be informative for early recognition and management of patients at risk for developing persistent rheumatic symptoms. Cryoglobulins failed to be identified in seronegative patients with invalidating dengue-like syndrome. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004145     DOI: 10.1016/j.jcv.2009.11.014

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  39 in total

1.  A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.

Authors:  Thomas E Morrison; Lauren Oko; Stephanie A Montgomery; Alan C Whitmore; Alina R Lotstein; Bronwyn M Gunn; Susan A Elmore; Mark T Heise
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

2.  Emerging and reemerging neurologic infections.

Authors:  Felicia C Chow; Carol A Glaser
Journal:  Neurohospitalist       Date:  2014-10

3.  Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus.

Authors:  Kristina A Stoermer; Adam Burrack; Lauren Oko; Stephanie A Montgomery; Luke B Borst; Ronald G Gill; Thomas E Morrison
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

4.  Clinical Manifestations Associated with Peripheral Joint Involvement in Patients with Acute Chikungunya Virus Infection.

Authors:  Mariangelí Arroyo-Ávila; Amanda Cabán; Enid J García-Rivera; Marisela Irizarry-Pérez; Hilda Torres; Héctor Gorbea; Luis M Vilá
Journal:  Am J Trop Med Hyg       Date:  2017-01-30       Impact factor: 2.345

5.  Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection.

Authors:  Weiqiang Chen; Suan-Sin Foo; Adam Taylor; Aleksei Lulla; Andres Merits; Linda Hueston; Mark R Forwood; Nicole C Walsh; Natalie A Sims; Lara J Herrero; Suresh Mahalingam
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

6.  Mutations in nsP1 and PE2 are critical determinants of Ross River virus-induced musculoskeletal inflammatory disease in a mouse model.

Authors:  Henri J Jupille; Lauren Oko; Kristina A Stoermer; Mark T Heise; Suresh Mahalingam; Bronwyn M Gunn; Thomas E Morrison
Journal:  Virology       Date:  2010-12-04       Impact factor: 3.616

7.  Comparative pathogenesis of epidemic and enzootic Chikungunya viruses in a pregnant Rhesus macaque model.

Authors:  Ching-I Chen; David C Clark; Patricia Pesavento; Nicholas W Lerche; Paul A Luciw; William K Reisen; Aaron C Brault
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

8.  Mutations in the E2 Glycoprotein and the 3' Untranslated Region Enhance Chikungunya Virus Virulence in Mice.

Authors:  David W Hawman; Kathryn S Carpentier; Julie M Fox; Nicholas A May; Wes Sanders; Stephanie A Montgomery; Nathaniel J Moorman; Michael S Diamond; Thomas E Morrison
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

9.  Attenuating mutations in nsP1 reveal tissue-specific mechanisms for control of Ross River virus infection.

Authors:  Kristina A Stoermer Burrack; David W Hawman; Henri J Jupille; Lauren Oko; Marissa Minor; Katherine D Shives; Bronwyn M Gunn; Kristin M Long; Thomas E Morrison
Journal:  J Virol       Date:  2014-01-15       Impact factor: 5.103

10.  Chikungunya Virus Infections Among Patients with Dengue-Like Illness at a Tertiary Care Hospital in the Philippines, 2012-2013.

Authors:  John Mark Velasco; Maria Theresa Valderama; Maria Nila Lopez; Domingo Chua; Rene Latog; Vito Roque; June Corpuz; Chonticha Klungthong; Prinyada Rodpradit; Kittinun Hussem; Yongyuth Poolpanichupatam; Louis Macareo; Stefan Fernandez; In-Kyu Yoon
Journal:  Am J Trop Med Hyg       Date:  2015-09-28       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.